Correction to: The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Works by Iino, Keiko
Results: 11
1
2
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 1, p. 2, doi. 10.1007/s12282-022-01403-8
- By:
- Publication type:
- Article
3
Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 1, p. 1, doi. 10.1007/s10147-020-01818-3
- By:
- Publication type:
- Article
4
Development of an educational program for healthcare professionals who provide appearance care for patients with cancer: Feasibility study of an e-learning program.
- Published in:
- Global Health & Medicine, 2023, v. 5, n. 6, p. 354, doi. 10.35772/ghm.2023.01035
- By:
- Publication type:
- Article
5
Profiling of the charged metabolites of traditional herbal medicines using capillary electrophoresis time-of-flight mass spectrometry.
- Published in:
- Metabolomics, 2012, v. 8, n. 1, p. 99, doi. 10.1007/s11306-011-0290-7
- By:
- Publication type:
- Article
6
Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
7
Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
8
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8
- By:
- Publication type:
- Article
9
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x
- By:
- Publication type:
- Article
10
Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
- By:
- Publication type:
- Article
11
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article